Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin ...

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients ...

Kerala Blasters thrashed Sporting Club Delhi 3-0 in its second AIFF Super Cup 2025-26 match played at the GMC Stadium in Bambolim on Monday.

A 26-year-old Momodu Mubarak Muhammed, a National Youth Service Corps (NYSC) member, has cried out for help from well-meaning ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat's ability to raise fetal hemoglobin (HbF) in adult patients with SCDIadademstat has demonstrated a favorable safet ...

Agios PharmaceuticalsAGIO incurred a loss of $1.78 per share in the third quarter of 2025, narrower than the Zacks Consensus ...

The first sickle cell disease patient has been enrolled in a Phase 1b trial testing iadademstat, Oryzon Genomics' ...

Vertex Pharmaceuticals (VRTX) is rated as a "Strong Buy" due to robust revenue growth and multiple expansion opportunities ...

The Phase 2 trial is evaluating SLS009 ... supporting SLS009 and its potential across hematologic malignancies,” said Angelos Stergiou, MD, ScD h.c., President and Chief Executive Officer of SELLAS ...

How Savannah area high school football teams fared in Week 12 of the season in their final games of the regular season.